Selectis Health (GBCS) EPS (Weighted Average and Diluted) (2010 - 2025)

Selectis Health has disclosed EPS (Weighted Average and Diluted) across 16 years of filings, most recently posting -$0.26 for Q4 2025.

• EPS (Weighted Average and Diluted) for Q4 2025 came in at -$0.26, down 30.0% year-over-year; the trailing twelve-month figure through Dec 2025 was -$0.34 (up 57.5% YoY), and the FY2025 annual result was -$0.34, up 57.5% from the prior year.
• EPS (Weighted Average and Diluted) came in at -$0.26 for Q4 2025 at Selectis Health, down from $0.24 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.32 in Q1 2023 to a low of -$1.2 in Q4 2023.
• The 5-year median for EPS (Weighted Average and Diluted) is -$0.24 (2025), against an average of -$0.2.
• Across the five-year window, EPS (Weighted Average and Diluted) surged 4507.64% in 2021 and plunged 1550.0% in 2022, its largest moves.
• Selectis Health's EPS (Weighted Average and Diluted) stood at -$0.64 in 2021, then fell by 12.5% to -$0.72 in 2022, then slumped by 66.67% to -$1.2 in 2023, then jumped by 83.33% to -$0.2 in 2024, then decreased by 30.0% to -$0.26 in 2025.
• The last three EPS (Weighted Average and Diluted) figures came in at -$0.26 (Q4 2025), $0.24 (Q3 2025), and -$0.1 (Q2 2025), per Business Quant data.